Average Co-Inventor Count = 3.15
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Numab Therapeutics Ag (8 from 12 patents)
2. Esbatech, an Alcon Biomedical Research Unit LLC (5 from 36 patents)
3. Tillotts Pharma Ag (3 from 32 patents)
4. Novartis Ag (2 from 3,923 patents)
5. Numab Innovation Ag (2 from 3 patents)
6. Other (1 from 832,891 patents)
7. Esbatech Ag (1 from 4 patents)
8. Namab Therapeutics Ag (1 from 1 patent)
9. Tillotts Pharm Ag (1 from 1 patent)
10. Oncalis Ag (0 patent)
24 patents:
1. 12209122 - Anti-TNF-alpha-antibodies and functional fragments thereof
2. 12209133 - Antibodies targeting CD137 and methods of use thereof
3. 12202911 - Multispecific antibody comprising CD137 binding domain and PDL1 binding domain
4. 12098203 - Hetero-dimeric multi-specific antibody format targeting at least CD3 and HSA
5. 12077588 - Antibodies targeting PDL1 and methods of use thereof
6. 12043663 - Anti-TNF-alpha-antibodies and functional fragments thereof
7. 11578133 - Antibodies targeting CD137 and methods of use thereof
8. 11578123 - Stable and soluble antibodies inhibiting TNFα
9. 11459383 - Anti-TNF-alpha-antibodies and functional fragments thereof
10. 11365240 - Anti-HSA antibodies
11. 11319371 - Anti-CD3 antibodies
12. 10975143 - Anti-TNF-α-antibodies and functional fragments thereof
13. 10787508 - Anti-TNFα-antibodies and functional fragments thereof
14. 10774140 - Anti-TNFα-antibodies and functional fragments thereof
15. 10759852 - Anti-TNF-alpha-antibodies and functional fragments thereof